✦ LIBER ✦

O02 RNA therapy approaches in myotonic dystrophy

✍ Scribed by C. Thornton

Book ID: 117670152
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 81 KB
Volume: 20
Category: Article
ISSN: 0960-8966
DOI: 10.1016/s0960-8966(10)70003-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O.6 Antisense approach for myotonic dyst

O.6 Antisense approach for myotonic dystrophy

✍ G. Gourdon; D. Furling; G. Bassez; J. Puymirat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Targeting nuclear RNA for in vivo correc

Targeting nuclear RNA for in vivo correction of myotonic dystrophy

✍ Wheeler, Thurman M.; Leger, Andrew J.; Pandey, Sanjay K.; MacLeod, A. Robert; Na 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 892 KB

Tackling the pathogenesis of RNA nuclear

Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy

✍ Nikolas P. Mastroyiannopoulos; Christos Shammas; Leonidas A. Phylactou 📂 Article 📅 2010 🏛 Portland Press 🌐 English ⚖ 284 KB

D.P.4.02 Dysphagia in Myotonic Dystrophy

D.P.4.02 Dysphagia in Myotonic Dystrophy type 2

✍ A.A. Tieleman; J. van Vliet; S. Knuijt; B.J.M. de Swart; R. Ensink; B.G.M. van E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

RNA toxicity in myotonic muscular dystro

RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression

✍ Yadava, Ramesh S; Frenzel-McCardell, Carla D; Yu, Qing; Srinivasan, Varadamurthy 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 655 KB

Perspectives on gene therapy in myotonic

Perspectives on gene therapy in myotonic dystrophy type 1

✍ Jonathan J. Magaña; Bulmaro Cisneros 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Myotonic dystrophy type 1 (DM1) is an autosomal dominant neuromuscular disorder caused by a CTG expansion mutation located in the 3 0 untranslated region of the DMPK (DM1 protein kinase) gene. According to current evidence, mutant DMPK mRNAs containing the trinucleotide expansion are retained in the